Background & Aims: The use of complementary and alternative medicine (CAM) in
| INTRODUC TI ON
Chronic hepatitis B (CHB) affects approximately 240 million people worldwide and the associated liver-related morbidity and mortality continue to rise. [1] [2] [3] Global migration is changing the epidemiology of CHB, especially in low-endemic regions (North-America, Europe) with a high immigration rate from highly endemic areas. 4, 5 These epidemiological shifts increase the ethno-cultural diversity, and could therefore influence the use of and perceptions on conventional
Western medicine and on complementary and alternative medicine (CAM).
Patients with chronic diseases increasingly use CAM in addition to, or as a replacement of conventional treatments. 6 CAM is defined as 'a group of diverse medical and health care systems, practices, and products that are not generally considered part of conventional medicine'. 7 Examples of CAM include Traditional
Chinese Medicine, acupuncture and dietary supplements. The proportion of patients with chronic liver disease who use CAM varies widely from 27% to 80%. [8] [9] [10] [11] Patients use CAM both for disease-related symptoms as well as for general well-being. 6 The identification of patterns in CAM use could be of great relevance to health care providers, since CAM products may interact with antiviral treatment or influence the health care-seeking behaviour of patients. 12, 13 Insight into CAM use is especially important for an ethnically diverse population such as those with CHB, where ethnic and acculturation factors can enlarge differences in CAM use and clinical outcomes.
The prevalence and predictors of individual CAM modalities in patients with CHB have not been well characterized. Previous studies on CAM use in CHB focused on specific types of CAM, were restricted to subgroups of patients, or evaluated few clinically important determinants. 9, 14, 15 We evaluated the use of various CAM modalities and its relation to clinical, socio-economic and migrationrelated factors in a large, multi-ethnic CHB cohort.
| PATIENTS AND ME THODS

| Study population
Patients with CHB aged 18 years or above who attended the hepa- 
| Data collection
To address CAM use in patients with CHB, we developed a modi- 
Key Points
• The use of complementary and alternative medicine was common in this clinic-based population of patients with chronic hepatitis B.
• Vitamin and mineral preparations were used most frequently, whereas compounds that might damage the liver were rarely consumed.
patients reported visits to CAM providers, the use of CAM products, the frequency and duration of use, the primary aim (treatment of acute or chronic symptoms of CHB, general well-being, other reason), the efficacy of CAM practice, (reasons for) non-disclosure and physician inquiry about of CAM use. 
| Statistical analysis
| RE SULTS
| Patient characteristics
A total of 600 patients were approached in the inclusion period, of whom 436 (73%) patients completed the survey. Patients were excluded due to the following: HBsAg negative (n = 7), relevant co-morbidity (n = 7), acute HBV (n = 2), or refusal to participate (n = 148). Sociodemographic and clinical characteristics of enrolled patients according to CAM use are shown in Table 1 were cirrhotic. Two-hundred and three (47%) patients had a family history of CHB.
Several characteristics were significantly different between CAM users and CAM non-users. Notably, CAM users were predominantly female, South-Asian or Black, had a higher socioeconomic status, and more often a family history of CHB. Other baseline characteristics were comparable between CAM users and CAM non-users.
| Patterns of CAM use
Three hundred nine (71%) patients had used CAM at least once during the past 12 months, and two hundred fifty-six (59%) patients had used CAM regularly (at least monthly; Figure 1 ). Biologically based (51%) and mind-body therapies (35%) were the most frequently utilized CAM domains. Within these domains, vitamin and mineral preparations (45%), spiritual practices (29%), and dietary supplements (21%) were the most common CAM modalities. The use of body-based therapies (24%) was moderate and the use of holistic practices (8.9%) was low.
CAM use was significantly different among different ethnicities (64% in Chinese, 72% in Caucasians, 76% in SE-Asians, 79% in SouthAsian, and 87% in Blacks; P = 0.03 (Table 1 and Table S1 ). Specifically, mind-body medicine was practised more often by South-Asian (54%)
and Black patients (77%) than other ethnic groups (22%; P < 0.005).
Homeopathy (2.8%) and naturopathy (1.4%) were more often used by Caucasian than other groups (P = 0.03). The overall use of vitamin and mineral preparations (45%) and herbal product use (16%)
did not differ significantly among ethnic groups. Vitamin and mineral supplements predominantly comprised of vitamin D (39%), multivitamins (38%), calcium (26%), vitamin C (19%), and omega-3 fatty acid (19%). Ginger extract (34%), milk thistle (15%) and ginseng (5.9%)
were the most commonly used herbal preparations.
The use of CAM products with a reported hepatoprotective or hepatitis B infection-altering effect (milk thistle and ginger extract) was very low (3%) and was not related to subjects' liver disease severity, as was reflected by no association with serum ALT, HBV DNA or presence of cirrhosis (P > 0.05). The use of green tea extract (9.2%) and St. John's wort (0.2%), the only known potentially harmful CAM products in this study, was not associated with liver disease severity (P > 0.05).
| Attitudes towards CAM use
The main reason to use herbal products was to improve general well-being (63%; Table 2 ). Thirty-two percent of patients used herbal products for liver-related symptoms, compared to 2.6% of vitamin and mineral product users (P < 0.005). Homeopathy and spiritual therapies were rated predominantly as very helpful, whereas most other CAM therapies were considered helpful. A quarter of patients rated vitamin/mineral (24%) and other supplements (25%) as not helpful at all. The majority of patients (87%) started CAM therapy before they were diagnosed with CHB and had been using it for at 
| Determinants of bio-holistic CAM use
Determinants for the use of the clinically most relevant CAM group, (bio-holistic CAM, were studied with logistic regression (Table 3 ).
The bio-holistic CAM therapies were selected because of possible clinical interactions and limited statistical power to study other Age, ethnicity, immigrant status, time since immigration, and primary language were not associated.
TA B L E 1 (Continued)
F
| D ISCUSS I ON
In this clinic-based study, we reported the prevalence of CAM use and individual CAM modalities in a large multi-ethnic CHB cohort, and examined factors that determined CAM usage. A majority of patients used CAM in the past year (71%), ranging from 64% for
Chinese to 78% in non-Asian patients. Vitamin and mineral preparations were used most frequently, followed by spiritual healing practices, body-based therapies and herbal medicine. Variables significantly associated with bio-holistic CAM use were female sex, higher socio-economic status, lower serum HBV DNA, and a family history of CHB; ethnicity and migration-related factors were not.
The use of CAM in our study was extensive compared to previous studies in CHB, but was not associated with the use of antiviral treatment or disease severity. Two previous studies in CHB reported that 46% of children used CAM, and 32% of patients in Hong Kong ever used Traditional Chinese Medicine, compared to 19% among Chinese patients in our study. 14, 15 Other epidemiological studies in non-CHB chronic liver disease showed substantial variation in CAM use rates (27%-80%). 8, 9, 11, 17 The comparatively high rate of CAM use in this study could be due to the comprehensive definition of CAM, the population under study, and the setting where patients were investigated (tertiary referral centre versus family practice).
18,19
Prolonged and/or frequent use of presumed noxious CAM compounds can adversely impact clinical disease markers in liver disease, due to herb-drug interactions or influence of cytochrome P450 systems. These findings mainly stem from studies in liver diseases other than CHB. [20] [21] [22] In our study, patients were taking mainly 'western style' CAM products (mostly vitamins) and hardly any herbals or supplements with possible beneficial effects for HBV or liver disease.
The use of potentially harmful CAM products such as green tea extract or St. John's wort was very low and not associated with liver disease severity, although this should be interpreted cautiously as few participants used these CAM products and no follow-up data was available. We are concerned when patients take a mix of herbs that are difficult to identify, but this did not occur frequently in our population, which was probably biased because all patients visited western style practitioners in a hospital. Alternatively, it might be possible that patients used CAM products which contained hepatotoxins but that they did not consider these as CAM. Nonetheless, this was the largest multi-ethnic clinic-based study in CHB and therefore probably indicative of real world CAM use in CHB in North-America.
In order to monitor the (safe) use of CAM, physicians should be encouraged to actively ask about CAM use and specific harmful products, which was currently only done by less than half of the treating physicians. 
TA B L E 3 (Continued)
This study was the first to investigate the influence of ethnicity on CAM modalities in North America, which contains a predominantly immigrant population with CHB. billion out-of-pocket annually on CAM visits and products, whereas one in every two European citizens uses CAM, which underlines the breadth of CAM use nowadays. 25, 26 Apart from reporting CAM use rates in chronic liver disease patients, it is equally important to gain insight in why patients opt for non-conventional medical therapies.
This study showed that most patients used CAM for reasons unrelated to their chronic liver disease, except for herbal medicine. A possible explanation is that the most commonly used herbal products milk thistle (Silybum marianum) and several Traditional Chinese
Medicine products have been associated with hepatoprotective effects, while the efficacy of other CAM therapies is less clear.
12,27-
30 Additionally, the non-liver related use of CAM could reflect an increasing demand for 'salutogenesis', an approach that focuses on determinants of well-being, rather than on determinants of disease, and is key to the CAM paradigm.
31
Strong aspects of this study are the inclusion of a large, multiethnic cohort of CHB patients who completed an extensive survey on CAM-related factors. Conversely, the inherent recall bias for questionnaires and cross-sectional design restricted us to study long-term consequences of CAM use. Future studies on CAM use in CHB could focus on these long-term effects and associated factors.
In summary, CAM use in this clinic-based population of CHB patients was common and the CAM products that patients used, primarily vitamin and mineral preparations, appeared to be safe. Few patients had used CAM products that were considered to be harmful. CAM use was associated with female sex, higher socio-economic status, lower HBV DNA and a family history of CHB; not with ethnic background, antiviral treatment or liver disease severity. Most treating physicians had not inquired about the use of CAM, neither had most of the patients discussed its use.
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